G3T Competitors and Similar CompaniesClear all
G3T's competitors and similar companies include Recursion Pharmaceuticals, OYAGEN, Strategic Partners and Limelight Bio.
 G3T G3 Therapeutics (G3T) is a biotechnology company that focuses on the development of therapeutics. |  Recursion Pharmaceuticals Recursion Pharmaceuticals is a company that offers drug discovery and treatments using artificial intelligence, automation, bioinformatics, and experimental biology. |  Strategic Partners Strategic Partners (formerly known as Orphazyme) is a company that forms partnerships with biotech, industrial, commercial, property, and asset management companies. |  Limelight Bio Limelight Bio is a multi-platform, multi-disease biopharmaceutical company developing novel gene therapies. | ||
Founding Date | Founding Date N/A | Founding Date 2013 | Founding Date 2003 | Founding Date 2009 | Founding Date 2016 |
Type | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Midlothian, US HQ | Locations Salt Lake City, US HQ | Locations Rochester, US HQ | Locations København, DK HQ Chicago, US Newton, US | Locations Philadelphia, US HQ Cambridge, US |
Employees | Employees 3 | Employees 216 | Employees 5 | Employees 1 | Employees 14 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2 b | Valuation ($) N/A | Valuation ($) 6.8 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $74.7m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) kr309k (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $71m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $3.7m (FY, 2025) | Gross profit N/A | Gross profit kr309k (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($644.8m) (FY, 2025) | Net income N/A | Net income (kr859k) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 150k (over 12 years ago) | Latest funding round N/A | Latest funding round $ 75m (over 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 437.1m | Total funding raised $ 5.9m | Total funding raised $ 58.8m | Total funding raised $ 75m |
For sources of this data, please see the company profile
View Company Profiles
Recursion Pharmaceuticals
HQ
Salt Lake City, US
Employees
216
Recursion Pharmaceuticals is a company that offers drug discovery and treatments using artificial intelligence, automation, bioinformatics, and experimental biology.
View company
OYAGEN
HQ
Rochester, US
Employees
5
OYAGEN is a biotech company focused on developing treatments for HIV.
View companyStrategic Partners
HQ
København, DK
Employees
1
Strategic Partners (formerly known as Orphazyme) is a company that forms partnerships with biotech, industrial, commercial, property, and asset management companies.
View companyLimelight Bio
HQ
Philadelphia, US
Employees
14
Limelight Bio is a multi-platform, multi-disease biopharmaceutical company developing novel gene therapies.
View company